AURA Aura Biosciences, Inc.: institutional ownership and insider trading
155 funds reported holding $696M of Aura Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $297M, with 35 new positions and 14 funds selling out; over the last 12 months insiders bought $0 and sold $40.0M on the open market.
AURA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$45.6M, EPS -0.48
- Quarter ended Mar 31, 2026: revenue n/a, net income −$33.7M, EPS -0.50
- Quarter ended Dec 31, 2025: revenue n/a, net income −$25.6M, EPS -0.34
- Quarter ended Sep 30, 2025: revenue n/a, net income −$26.1M, EPS -0.40
Famous investors holding AURA
- Izzy Englander (Millennium Management): $4.38M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.24M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $479K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $369K, 0.0% of the portfolio
Largest institutional holders of AURA
- TCG Crossover Management, LLC — $67.7M
- SUVRETTA CAPITAL MANAGEMENT, LLC — $51.2M
- Frazier Life Sciences Management, L.P. — $50.4M
- Long Focus Capital Management, LLC — $36.3M
- BlackRock, Inc. (BLK) — $33.4M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $32.9M
- Caligan Partners LP — $30.5M
- VANGUARD CAPITAL MANAGEMENT LLC — $29.1M
- FCPM III SERVICES B.V. — $28.8M
- ORBIMED ADVISORS LLC — $23.7M
Recent AURA insider trades
- Jun 16, 2026: Gibney Anthony S sold 12,824 shares ($82.3K)
- May 7, 2026: Matrix Capital Management Company, LP sold 6,922,870 shares ($39.0M)
- Apr 16, 2026: Kilroy Conor sold 11,738 shares ($82.4K)
- Feb 17, 2026: de los Pinos Elisabet sold 47,648 shares ($241K)
5%+ owners
- Chen Yu: 9.9% (Schedule 13G, filed May 12, 2026)
- Adage Capital Management, L.P.: 8.4% (Schedule 13G/A, filed Aug 12, 2026)
- Frazier Life Sciences Public Fund, L.P.: 5.6% (Schedule 13G/A, filed Aug 14, 2026)
- ForGrowth III PA B.V.: 5.1% (Schedule 13G, filed Oct 1, 2026)
Who owns the most AURA stock?
The largest institutional holders of Aura Biosciences, Inc. in the latest 13F filings are TCG Crossover Management, LLC ($67.7M), SUVRETTA CAPITAL MANAGEMENT, LLC ($51.2M), Frazier Life Sciences Management, L.P. ($50.4M).
Are insiders buying or selling AURA?
Over the last 12 months insiders bought $0 and sold $40.0M of Aura Biosciences, Inc. stock on the open market (SEC Form 4).
Which famous investors own AURA?
Izzy Englander, Renaissance Technologies, D. E. Shaw, Ken Griffin.
Which ETFs hold AURA?
3 ETFs and mutual funds hold it among their top 100 positions, including FBDIX, BBC, AEDFX.